Expansion into San Diego County strengthens local service, creates jobs and deepens community impact

SAN DIEGO, April 21, 2026 /PRNewswire/ — Meathead Movers, California’s largest independent moving company, announced the opening of its first office in San Diego County at 1220 Keystone Way in Vista. The expansion brings the company’s premier moving, packing and storage services to a region experiencing strong population growth and rising relocation demand.

As the company approaches its 30th anniversary and expands to eight offices across California, the Vista opening follows hundreds of inquiries from San Diego County residents and enables Meathead Movers to better support the region through more competitive rates and lower hourly minimums.

“We’ve always served San Diego County, but this new location allows us to elevate our services and deepen our local impact,” said Aaron Steed, Founder and CEO of Meathead Movers. “We’re seeing strong momentum in the local housing market, with an increase in moves to and within San Diego County. Given the strong demand from residents, opening this North County location is a natural next step in expanding our statewide presence and enhancing service in Southern California.”

Meathead Movers hires and trains athletes of all ages to deliver a faster, safer and more efficient moving experience. From local to long-distance moves, packing and storage, the company provides white-glove, customer-first service backed by a 100% money-back guarantee. Its crews jog between loads to save customers time and money.

Beyond its core services, Meathead Movers is committed to giving back, having completed thousands of free moves for survivors of domestic violence to help them regain stability. The company has partnered with Oceanside’s Women’s Resource Center to provide unlimited free moves for those fleeing domestic violence, along with $20,000 in additional support for housing transitions and shelter operations. It has also engaged with local chambers of commerce and realtor associations to strengthen community ties and support the region.

Meathead Movers is hiring in Vista, with plans for up to 50 team members. The company is seeking athletes to join the team, offering opportunities to stay active while developing leadership and transferable skills through structured training and clear paths for growth and advancement.

For more information or to apply, visit www.meatheadmovers.com.

About Meathead Movers
Founded in 1997, Meathead Movers is California’s largest independent moving company, redefining the moving experience with clean-cut athletes who bring professionalism, energy and care to every move. From local to long-distance moves, packing and storage, crews jog between loads to save customers time and money. Every Meathead move comes with white-glove service and a 100% money-back guarantee.

Beyond moving services, Meathead Movers is committed to giving back. In partnership with local shelters and organizations, they provide free moving assistance to survivors of domestic violence, helping individuals and families relocate safely and start fresh. Meathead Movers doesn’t just move belongings, it moves people forward. To learn more visit www.meatheadmovers.com.

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/meathead-movers-meets-growing-san-diego-demand-with-new-vista-office-302748878.html

SOURCE Meathead Movers

EcoVadis recognition and SBTi validation reflect Technimark’s approach to driving growth, efficiency, and customer value through responsible business practices

ASHEBORO, N.C., April 21, 2026 /PRNewswire/ — Technimark, a global leader in the design and manufacturing of custom, highly engineered injection-molded components for healthcare, consumer, and specialty industrial applications, has earned its second EcoVadis Gold Medal, placing the company among the top 2% of rated companies worldwide and in the top 1% of its industry.

EcoVadis, one of the world’s largest providers of business sustainability ratings, evaluates companies across environment, labor and human rights, ethics, and sustainable procurement. Technimark’s results demonstrate steady progress in these areas – each of which plays a direct role in how the company operates, manages risk, and delivers value to customers.

“Sustainability is fundamental to how we operate and win. It is not a separate initiative – it is how we run the business,” said Brad Wellington, Chief Executive Officer of Technimark. “It improves efficiency and reduces risk, while also driving innovation across our teams and processes. Simply put, these are the decisions that make us a stronger and more competitive company.”

Over the past year, Technimark has continued to invest across its People, Planet, and Product priorities – strengthening employee engagement and safety, reducing energy use and waste, while also advancing innovation in more sustainable product design. These efforts are directly tied to business performance, helping improve productivity, lower costs, and reduce disruption across the company and its broader supply chain.

In late 2025, the company’s greenhouse gas reduction targets were validated by the Science Based Targets initiative (SBTi), aligned with limiting global warming to 1.5°C. For Technimark, this work is as much about operational discipline as environmental impact — reducing energy intensity, mitigating climate-related risks, and helping customers lower the footprint of their products.

“This recognition reflects a disciplined, performance-driven approach to sustainability,” said Katie Distler, Technimark’s Chief Sustainability Officer. “We focus on the areas that materially impact performance — energy, supply chain, product design, and how we support our people. The result is better execution, stronger partnerships with our customers and suppliers, and a more resilient operation.”

Technimark continues to earn “Best in Class” distinctions from customers, reflecting how its approach to responsible business practices drives stronger performance and a more effective operating model – creating a clear competitive advantage in the markets it serves.

About Technimark

Technimark is a global manufacturing solutions partner for the healthcare, consumer packaging, and specialty industrial sectors, specializing in precision injection molding, value-added assembly, and contract manufacturing, including medical devices. Technimark provides customized, end-to-end solutions focused on technology and innovation that improve quality, lower risk, and reduce costs. With facilities in the United States, Mexico, United Kingdom, Ireland, and China, Technimark leverages its global footprint to deliver high-quality products worldwide. Technimark is owned by Oak Hill Capital and Pritzker Private Capital. See the Technimark difference at technimark.com.

Contact:
Technimark Communications
communications@technimark.com
919-624-1772

Cision View original content:https://www.prnewswire.com/news-releases/technimark-earns-second-ecovadis-gold-medal-for-sustainability-ranking-in-top-1-of-its-industry-302748815.html

SOURCE Technimark LLC

EcoVadis recognition and SBTi validation reflect Technimark’s approach to driving growth, efficiency, and customer value through responsible business practices

ASHEBORO, N.C., April 21, 2026 /PRNewswire/ — Technimark, a global leader in the design and manufacturing of custom, highly engineered injection-molded components for healthcare, consumer, and specialty industrial applications, has earned its second EcoVadis Gold Medal, placing the company among the top 2% of rated companies worldwide and in the top 1% of its industry.

EcoVadis, one of the world’s largest providers of business sustainability ratings, evaluates companies across environment, labor and human rights, ethics, and sustainable procurement. Technimark’s results demonstrate steady progress in these areas – each of which plays a direct role in how the company operates, manages risk, and delivers value to customers.

“Sustainability is fundamental to how we operate and win. It is not a separate initiative – it is how we run the business,” said Brad Wellington, Chief Executive Officer of Technimark. “It improves efficiency and reduces risk, while also driving innovation across our teams and processes. Simply put, these are the decisions that make us a stronger and more competitive company.”

Over the past year, Technimark has continued to invest across its People, Planet, and Product priorities – strengthening employee engagement and safety, reducing energy use and waste, while also advancing innovation in more sustainable product design. These efforts are directly tied to business performance, helping improve productivity, lower costs, and reduce disruption across the company and its broader supply chain.

In late 2025, the company’s greenhouse gas reduction targets were validated by the Science Based Targets initiative (SBTi), aligned with limiting global warming to 1.5°C. For Technimark, this work is as much about operational discipline as environmental impact — reducing energy intensity, mitigating climate-related risks, and helping customers lower the footprint of their products.

“This recognition reflects a disciplined, performance-driven approach to sustainability,” said Katie Distler, Technimark’s Chief Sustainability Officer. “We focus on the areas that materially impact performance — energy, supply chain, product design, and how we support our people. The result is better execution, stronger partnerships with our customers and suppliers, and a more resilient operation.”

Technimark continues to earn “Best in Class” distinctions from customers, reflecting how its approach to responsible business practices drives stronger performance and a more effective operating model – creating a clear competitive advantage in the markets it serves.

About Technimark

Technimark is a global manufacturing solutions partner for the healthcare, consumer packaging, and specialty industrial sectors, specializing in precision injection molding, value-added assembly, and contract manufacturing, including medical devices. Technimark provides customized, end-to-end solutions focused on technology and innovation that improve quality, lower risk, and reduce costs. With facilities in the United States, Mexico, United Kingdom, Ireland, and China, Technimark leverages its global footprint to deliver high-quality products worldwide. Technimark is owned by Oak Hill Capital and Pritzker Private Capital. See the Technimark difference at technimark.com.

Contact:
Technimark Communications
communications@technimark.com
919-624-1772

Cision View original content:https://www.prnewswire.com/news-releases/technimark-earns-second-ecovadis-gold-medal-for-sustainability-ranking-in-top-1-of-its-industry-302748815.html

SOURCE Technimark LLC

EcoVadis recognition and SBTi validation reflect Technimark’s approach to driving growth, efficiency, and customer value through responsible business practices

ASHEBORO, N.C., April 21, 2026 /PRNewswire/ — Technimark, a global leader in the design and manufacturing of custom, highly engineered injection-molded components for healthcare, consumer, and specialty industrial applications, has earned its second EcoVadis Gold Medal, placing the company among the top 2% of rated companies worldwide and in the top 1% of its industry.

EcoVadis, one of the world’s largest providers of business sustainability ratings, evaluates companies across environment, labor and human rights, ethics, and sustainable procurement. Technimark’s results demonstrate steady progress in these areas – each of which plays a direct role in how the company operates, manages risk, and delivers value to customers.

“Sustainability is fundamental to how we operate and win. It is not a separate initiative – it is how we run the business,” said Brad Wellington, Chief Executive Officer of Technimark. “It improves efficiency and reduces risk, while also driving innovation across our teams and processes. Simply put, these are the decisions that make us a stronger and more competitive company.”

Over the past year, Technimark has continued to invest across its People, Planet, and Product priorities – strengthening employee engagement and safety, reducing energy use and waste, while also advancing innovation in more sustainable product design. These efforts are directly tied to business performance, helping improve productivity, lower costs, and reduce disruption across the company and its broader supply chain.

In late 2025, the company’s greenhouse gas reduction targets were validated by the Science Based Targets initiative (SBTi), aligned with limiting global warming to 1.5°C. For Technimark, this work is as much about operational discipline as environmental impact — reducing energy intensity, mitigating climate-related risks, and helping customers lower the footprint of their products.

“This recognition reflects a disciplined, performance-driven approach to sustainability,” said Katie Distler, Technimark’s Chief Sustainability Officer. “We focus on the areas that materially impact performance — energy, supply chain, product design, and how we support our people. The result is better execution, stronger partnerships with our customers and suppliers, and a more resilient operation.”

Technimark continues to earn “Best in Class” distinctions from customers, reflecting how its approach to responsible business practices drives stronger performance and a more effective operating model – creating a clear competitive advantage in the markets it serves.

About Technimark

Technimark is a global manufacturing solutions partner for the healthcare, consumer packaging, and specialty industrial sectors, specializing in precision injection molding, value-added assembly, and contract manufacturing, including medical devices. Technimark provides customized, end-to-end solutions focused on technology and innovation that improve quality, lower risk, and reduce costs. With facilities in the United States, Mexico, United Kingdom, Ireland, and China, Technimark leverages its global footprint to deliver high-quality products worldwide. Technimark is owned by Oak Hill Capital and Pritzker Private Capital. See the Technimark difference at technimark.com.

Contact:
Technimark Communications
communications@technimark.com
919-624-1772

Cision View original content:https://www.prnewswire.com/news-releases/technimark-earns-second-ecovadis-gold-medal-for-sustainability-ranking-in-top-1-of-its-industry-302748815.html

SOURCE Technimark LLC

  • Solvents made from renewable feedstocks help reduce reliance on fossil-fuel-based materials
  • Drop-in replacements preserve established chromatography performance
  • Supports progress toward sustainability targets by lowering product-related greenhouse gas emissions

BURLINGTON, Mass., April 21, 2026 /3BL/ – MilliporeSigma, the U.S. and Canada Life Science business of Merck KGaA, Darmstadt, Germany, a leading science and technology company, today announced the launch of the first bio-based solvent portfolio specifically for high-performance liquid chromatography (HPLC). Manufactured using renewable feedstocks, these new patent-pending1 solvents deliver on average 25.9% lower CO2 equivalents2 compared with conventional fossil-fuel-based HPLC-grade solvents, while preserving the performance required for demanding analytical workflows.

“Our new bio-based HPLC solvents represent the next generation of high-performance liquid chromatography,” said Karen Madden, Chief Technology Officer, Life Science business of Merck KGaA, Darmstadt, Germany. “Customers are looking for solutions that help reduce environmental impact without compromising performance quality. This innovative portfolio aims to deliver the precision, quality and reliability expected in HPLC and is designed to integrate seamlessly into existing methods.”

These bio-based solvents are compatible with established HPLC and liquid chromatography mass spectrometry (LC-MS) methods and instruments, supporting easy adoption in routine and regulated environments. In HPLC, solvents serve as the mobile phase that transports samples through the chromatographic system, enabling separation and quantification of components. This step is critical for generating reliable data in applications such as drug development, quality control in manufacturing, environmental monitoring and diagnostics.

MilliporeSigma developed this innovative portfolio using proprietary manufacturing processes and deep scientific expertise, reinforcing the company’s commitment to advancing more sustainable, high-performance chromatography solutions. The new portfolio includes drop-in replacements for acetonitrile, methanol and ethanol. Because these newly launched bio-based solvents are designed to match conventional performance, laboratories can transition to these alternatives without redeveloping analytical methods, often a rigorous and lengthy process.

This launch further expands MilliporeSigma’s range of greener alternatives designed to help customers reduce environmental impact while preserving the precision and reliability laboratories expect. The new bio-based solvents reflect the company’s broader strategic focus on innovation that supports more sustainable science.

The bio-based HPLC solvents are available on sigmaaldrich.com/Bio-based-HPLC-Solvents.

1 Patent applications pending on bio-based methanol and acetonitrile.

2 Individual bio-based HPLC solvent CO2e values compared to fossil-fuel-based alternatives are as follows, based on supplier and industry emissions data through EcoInvent: Acetonitrile, BioRenewable, gradient grade for LC (Prod. No. 104771) has a 28% lower CO2e impact; Methanol, BioRenewable, gradient grade for LC (Prod. No. 106188) has a 29% lower CO2e impact; Methanol, BioRenewable, hypergrade for LC-MS (Prod. No. 106176) has a 29% lower CO2e impact; Ethanol, BioRenewable, hypergrade for LC-MS (Prod. No. 117480) has a 17.6% lower CO2e impact.

About the Life Science business of Merck KGaA, Darmstadt, Germany

The Life Science business of Merck KGaA, Darmstadt, Germany, which operates as MilliporeSigma in the U.S. and Canada, has more than 27,000 employees and more than 55 total manufacturing and testing sites worldwide, with a portfolio of more than 300,000 products focused on scientific discovery, biomanufacturing and testing services. Merck KGaA, Darmstadt, Germany, a leading science and technology company, operates across healthcare, life science and electronics.

More than 62,000 employees work to make a positive difference to millions of people’s lives every day by creating more joyful and sustainable ways to live. From providing products and services that accelerate drug development and manufacturing as well as discovering unique ways to treat the most challenging diseases to enabling the intelligence of devices – the company is everywhere. In 2025, Merck KGaA, Darmstadt, Germany, generated sales of € 21.1 billion in 65 countries.

The company holds the global rights to the name and trademark “Merck” internationally. The only exceptions are the United States and Canada, where the business sectors of Merck KGaA, Darmstadt, Germany, operate as MilliporeSigma in life science, EMD Serono in healthcare and EMD Electronics in electronics. Since its founding in 1668, scientific exploration and responsible entrepreneurship have been key to the company’s technological and scientific advances. To this day, the founding family remains the majority owner of the publicly listed company. For more information about Merck KGaA, Darmstadt, Germany, visit www.emdgroup.com.

Follow MilliporeSigma on X (formerly Twitter) @MilliporeSigma, on Facebook @MilliporeSigma and on LinkedIn.

  • Solvents made from renewable feedstocks help reduce reliance on fossil-fuel-based materials
  • Drop-in replacements preserve established chromatography performance
  • Supports progress toward sustainability targets by lowering product-related greenhouse gas emissions

BURLINGTON, Mass., April 21, 2026 /3BL/ – MilliporeSigma, the U.S. and Canada Life Science business of Merck KGaA, Darmstadt, Germany, a leading science and technology company, today announced the launch of the first bio-based solvent portfolio specifically for high-performance liquid chromatography (HPLC). Manufactured using renewable feedstocks, these new patent-pending1 solvents deliver on average 25.9% lower CO2 equivalents2 compared with conventional fossil-fuel-based HPLC-grade solvents, while preserving the performance required for demanding analytical workflows.

“Our new bio-based HPLC solvents represent the next generation of high-performance liquid chromatography,” said Karen Madden, Chief Technology Officer, Life Science business of Merck KGaA, Darmstadt, Germany. “Customers are looking for solutions that help reduce environmental impact without compromising performance quality. This innovative portfolio aims to deliver the precision, quality and reliability expected in HPLC and is designed to integrate seamlessly into existing methods.”

These bio-based solvents are compatible with established HPLC and liquid chromatography mass spectrometry (LC-MS) methods and instruments, supporting easy adoption in routine and regulated environments. In HPLC, solvents serve as the mobile phase that transports samples through the chromatographic system, enabling separation and quantification of components. This step is critical for generating reliable data in applications such as drug development, quality control in manufacturing, environmental monitoring and diagnostics.

MilliporeSigma developed this innovative portfolio using proprietary manufacturing processes and deep scientific expertise, reinforcing the company’s commitment to advancing more sustainable, high-performance chromatography solutions. The new portfolio includes drop-in replacements for acetonitrile, methanol and ethanol. Because these newly launched bio-based solvents are designed to match conventional performance, laboratories can transition to these alternatives without redeveloping analytical methods, often a rigorous and lengthy process.

This launch further expands MilliporeSigma’s range of greener alternatives designed to help customers reduce environmental impact while preserving the precision and reliability laboratories expect. The new bio-based solvents reflect the company’s broader strategic focus on innovation that supports more sustainable science.

The bio-based HPLC solvents are available on sigmaaldrich.com/Bio-based-HPLC-Solvents.

1 Patent applications pending on bio-based methanol and acetonitrile.

2 Individual bio-based HPLC solvent CO2e values compared to fossil-fuel-based alternatives are as follows, based on supplier and industry emissions data through EcoInvent: Acetonitrile, BioRenewable, gradient grade for LC (Prod. No. 104771) has a 28% lower CO2e impact; Methanol, BioRenewable, gradient grade for LC (Prod. No. 106188) has a 29% lower CO2e impact; Methanol, BioRenewable, hypergrade for LC-MS (Prod. No. 106176) has a 29% lower CO2e impact; Ethanol, BioRenewable, hypergrade for LC-MS (Prod. No. 117480) has a 17.6% lower CO2e impact.

About the Life Science business of Merck KGaA, Darmstadt, Germany

The Life Science business of Merck KGaA, Darmstadt, Germany, which operates as MilliporeSigma in the U.S. and Canada, has more than 27,000 employees and more than 55 total manufacturing and testing sites worldwide, with a portfolio of more than 300,000 products focused on scientific discovery, biomanufacturing and testing services. Merck KGaA, Darmstadt, Germany, a leading science and technology company, operates across healthcare, life science and electronics.

More than 62,000 employees work to make a positive difference to millions of people’s lives every day by creating more joyful and sustainable ways to live. From providing products and services that accelerate drug development and manufacturing as well as discovering unique ways to treat the most challenging diseases to enabling the intelligence of devices – the company is everywhere. In 2025, Merck KGaA, Darmstadt, Germany, generated sales of € 21.1 billion in 65 countries.

The company holds the global rights to the name and trademark “Merck” internationally. The only exceptions are the United States and Canada, where the business sectors of Merck KGaA, Darmstadt, Germany, operate as MilliporeSigma in life science, EMD Serono in healthcare and EMD Electronics in electronics. Since its founding in 1668, scientific exploration and responsible entrepreneurship have been key to the company’s technological and scientific advances. To this day, the founding family remains the majority owner of the publicly listed company. For more information about Merck KGaA, Darmstadt, Germany, visit www.emdgroup.com.

Follow MilliporeSigma on X (formerly Twitter) @MilliporeSigma, on Facebook @MilliporeSigma and on LinkedIn.

  • Solvents made from renewable feedstocks help reduce reliance on fossil-fuel-based materials
  • Drop-in replacements preserve established chromatography performance
  • Supports progress toward sustainability targets by lowering product-related greenhouse gas emissions

BURLINGTON, Mass., April 21, 2026 /3BL/ – MilliporeSigma, the U.S. and Canada Life Science business of Merck KGaA, Darmstadt, Germany, a leading science and technology company, today announced the launch of the first bio-based solvent portfolio specifically for high-performance liquid chromatography (HPLC). Manufactured using renewable feedstocks, these new patent-pending1 solvents deliver on average 25.9% lower CO2 equivalents2 compared with conventional fossil-fuel-based HPLC-grade solvents, while preserving the performance required for demanding analytical workflows.

“Our new bio-based HPLC solvents represent the next generation of high-performance liquid chromatography,” said Karen Madden, Chief Technology Officer, Life Science business of Merck KGaA, Darmstadt, Germany. “Customers are looking for solutions that help reduce environmental impact without compromising performance quality. This innovative portfolio aims to deliver the precision, quality and reliability expected in HPLC and is designed to integrate seamlessly into existing methods.”

These bio-based solvents are compatible with established HPLC and liquid chromatography mass spectrometry (LC-MS) methods and instruments, supporting easy adoption in routine and regulated environments. In HPLC, solvents serve as the mobile phase that transports samples through the chromatographic system, enabling separation and quantification of components. This step is critical for generating reliable data in applications such as drug development, quality control in manufacturing, environmental monitoring and diagnostics.

MilliporeSigma developed this innovative portfolio using proprietary manufacturing processes and deep scientific expertise, reinforcing the company’s commitment to advancing more sustainable, high-performance chromatography solutions. The new portfolio includes drop-in replacements for acetonitrile, methanol and ethanol. Because these newly launched bio-based solvents are designed to match conventional performance, laboratories can transition to these alternatives without redeveloping analytical methods, often a rigorous and lengthy process.

This launch further expands MilliporeSigma’s range of greener alternatives designed to help customers reduce environmental impact while preserving the precision and reliability laboratories expect. The new bio-based solvents reflect the company’s broader strategic focus on innovation that supports more sustainable science.

The bio-based HPLC solvents are available on sigmaaldrich.com/Bio-based-HPLC-Solvents.

1 Patent applications pending on bio-based methanol and acetonitrile.

2 Individual bio-based HPLC solvent CO2e values compared to fossil-fuel-based alternatives are as follows, based on supplier and industry emissions data through EcoInvent: Acetonitrile, BioRenewable, gradient grade for LC (Prod. No. 104771) has a 28% lower CO2e impact; Methanol, BioRenewable, gradient grade for LC (Prod. No. 106188) has a 29% lower CO2e impact; Methanol, BioRenewable, hypergrade for LC-MS (Prod. No. 106176) has a 29% lower CO2e impact; Ethanol, BioRenewable, hypergrade for LC-MS (Prod. No. 117480) has a 17.6% lower CO2e impact.

About the Life Science business of Merck KGaA, Darmstadt, Germany

The Life Science business of Merck KGaA, Darmstadt, Germany, which operates as MilliporeSigma in the U.S. and Canada, has more than 27,000 employees and more than 55 total manufacturing and testing sites worldwide, with a portfolio of more than 300,000 products focused on scientific discovery, biomanufacturing and testing services. Merck KGaA, Darmstadt, Germany, a leading science and technology company, operates across healthcare, life science and electronics.

More than 62,000 employees work to make a positive difference to millions of people’s lives every day by creating more joyful and sustainable ways to live. From providing products and services that accelerate drug development and manufacturing as well as discovering unique ways to treat the most challenging diseases to enabling the intelligence of devices – the company is everywhere. In 2025, Merck KGaA, Darmstadt, Germany, generated sales of € 21.1 billion in 65 countries.

The company holds the global rights to the name and trademark “Merck” internationally. The only exceptions are the United States and Canada, where the business sectors of Merck KGaA, Darmstadt, Germany, operate as MilliporeSigma in life science, EMD Serono in healthcare and EMD Electronics in electronics. Since its founding in 1668, scientific exploration and responsible entrepreneurship have been key to the company’s technological and scientific advances. To this day, the founding family remains the majority owner of the publicly listed company. For more information about Merck KGaA, Darmstadt, Germany, visit www.emdgroup.com.

Follow MilliporeSigma on X (formerly Twitter) @MilliporeSigma, on Facebook @MilliporeSigma and on LinkedIn.

The 22nd annual event convened nearly 500 attendees from 13 countries, featuring insightful scientific presentations, panels, and a keynote session by 18th U.S. Surgeon General Dr. Regina Benjamin, following a groundbreaking medical student breakfast program.

CHICAGO, April 21, 2026 /PRNewswire/ — The Skin of Color Society (SOCS), the world’s leading professional society dedicated to advancing skin of color dermatology, successfully presented its 22nd Annual Scientific Symposium, “Championing Evidence-Based Dermatology and Collaboration,” on March 26, 2026, in Denver, Colorado. Held in conjunction with the American Academy of Dermatology (AAD) Annual Meeting, this signature SOCS program convened nearly 500 attendees from 13 countries.

 

Drs. Janiene Luke and Temitayo Ogunleye co-chaired the dynamic program developed under the leadership of the SOCS Scientific Meetings Committee. The innovative scientific program showcased insights from highly recognized experts, dermatology leaders, and emerging researchers, featuring the following presentations:

  • Welcome remarks by SOCS President Dr. Nada Elbuluk (now Immediate Past President)
  • Keynote session, Making a Difference, presented by Dr. Regina Benjamin
  • Leadership During Turbulent Times presented by SOCS Founder Dr. Susan C. Taylor
  • Tumor Microenvironment Signatures in CTCL: Implications for Personalized Medicine, presented by Dr. Courtney M. Johnson, 2021 Dermatology Research Award Recipient
  • Risk of Psychiatric Comorbidities in Scarring vs Non-Scarring Alopecia: A Retrospective Cohort Study, an oral abstract presented by Nicole J. Baker, BS
  • Presentations by Early Career Innovations Award Finalists, judged by award founder Dr. Dhaval Bhanusali, and Drs. Tiffany Mayo and Roopal Kundu:
    • Short Wave Infrared (SWIR) Imaging to Detect Early Hair Regrowth in Alopecia presented by Angela Anaeme, BS, Washington University in St. Louis School of Medicine
    • LearnDx, presented by Priyanka Kadam, BS, Stony Brook University Renaissance School of Medicine
  • Limitations for Gender Affirming Care in Challenging Times, presented by Dr. Klint Peebles
  • Holistic Patient Care & Advocacy Panel, moderated by Dr. Heather Woolery-Lloyd with panelists Drs. Michelle Oboite, Klint Peebles, and Rebecca Vasquez
  • Distinct Metabolic Pathways of Hidradenitis Suppurativa and Severity-Associated Biomarkers, an oral abstract presented by Kingsley Osei-Karikari, BA, Weill Cornell Medical College, 4th Year Medical Student
  • Perioperative Racial Disparities in Patients with Acral Lentiginous Melanoma Undergoing Mohs Micrographic Surgery, an oral abstract presented by Umayr R. Shaikh, MPH
  • Leveraging AI to Build a More Sustainable Dermatology Practice presented by Dr. Vinod E. Nambudiri
  • Physician Care & Wellness: Practical Strategies for Sustainable Practice Panel, moderated by Dr. Noreen Galaria, with panelists Drs. Naana A. Boakye, Vinod E. Nambudiri, Karolyn Wanat, and Heather Woolery-Lloyd
  • Closing remarks by Dr. Nada Elbuluk

In addition to these formal presentations, several scientific iPosters developed by emerging skin of color dermatology researchers were featured during the program breaks throughout the afternoon.

The 22nd Annual SOCS Scientific Symposium was made possible thanks to the generous support of the following sponsors: AbbVie and Johnson & Johnson (Champion Level); Arcutis Biotherapeutics, Bristol Myers Squibb, Clinique, Eli Lilly & Co, Incyte, Sanofi and Regeneron (Ally level); Pfizer and UCB (Partner level); Beiersdorf, Biogen, Clinuvel, LEO Pharmaceuticals, Organon, Ortho Dermatologics, Takeda, and Vaseline (Friend level); Dr. Dhaval Bhanusali, EltaMD Skincare, Novartis, SkinCeuticals, Sun Pharmaceuticals (Special Acknowledgements).

Additional support for the Society’s work was made possible thanks to individual donors to the SOCS Foundation, who received special access to a Donor Wellness Lounge throughout the day.

2026 Grants and Awards Presented
Several prestigious SOCS awards, grants, and special recognition were presented during the Symposium, including: 

SOCS Career Development Award 
Dr. Leandra A. Barnes, Stanford Medicine, Department of Dermatology, for “Investigating the Role of Geospatial Social Determinants of Health in Diagnosis and Healthcare Inequities in Hidradenitis Suppurativa (HS): A Mixed-Methods and Machine Learning Approach.”

2026 Dermatology Research Award
Dr. William Lewis, Beth Israel Deaconess Medical Center, Harvard Medical School, for “Clinical Validation of an Erythema Imaging Tool for Assessment of Inflammation in Skin of Color.”     

2026 Dermatology Foundation-Skin of Color Society Collaborative Mid-Career Award sponsored by Sanofi and Regeneron

  • Dr. Angel S. Byrd, Howard University, for “Understanding the Role of Pathogen-Mediated Immune Dysregulation in Hidradenitis Suppurativa.” (Special bestowal of available 2025 funding.) 
  • Dr. Tarannum Jaleel, Duke University Medical Center Dermatology, for “AR Signaling and CXCL12-Mediated Neutrophil Retention in Hidradenitis Suppurativa.”

2026 Early Career Innovations Award
Priyanka Kadam, BS, Stony Brook University Renaissance School of Medicine for Learn Dx.
This award is made possible thanks to Dr. Dhaval Bhanusali and EltaMD Skincare.

2026 Institutional Research Fellowship Awards
Duke University
University of Pennsylvania
This award is sponsored by Johnson & Johnson.

The Center for Leadership Resident Leader Award 
Dr. Kala Hurst, Dermatology Resident PGY-4, Case Western Reserve University, University Hospitals.
This award is supported by Eli Lilly & Co.

2026 Best iPoster Presentation
Shirin Shahsavari, BS, Johns Hopkins University School of Medicine, Department of Dermatology, for “Tumor Microenvironment Remodeling in Mycosis Fungoides Across Diverse Patient Cohorts Revealed by Single-Cell Transcriptomics.”

2026 Best Oral Abstract Presentation
Umayr R. Shaikh, MPH, Georgetown University, School of Medicine, 4th Year Medical Student for “Perioperative Racial Disparities in Patients with Acral Lentiginous Melanoma Undergoing Mohs Micrographic Surgery.”

Inaugural SOCS Awards
In recognition of extraordinary contributions to the specialty, SOCS Founder Dr. Susan C. Taylor received the Skin of Color Champion of the Year, and Past President and Founding Member Dr. Valerie C. Callender received the Mentor of the Year Award.

Clinical Investigator Training and Mentorship Program
Mentors and mentees from the 2024, 2025, and 2026 cohorts were recognized for their participation in this groundbreaking training and mentorship initiative presented collaboratively by SOCS and the National Medical Association (NMA) Dermatology Section, listed here.
This program is supported by Johnson & Johnson.

Dermatologists of Tomorrow Scholarship (DOTS) presented by SOCS Foundation (SOCSF) and Cliniqu
We are proud to continue our partnership with Clinique via the Dermatologists of Tomorrow Scholarship (DOTS).  Rooted in mentorship, this pioneering partnership was built to provide support to medical students interested in pursuing careers in dermatology and health equity. The Symposium celebrated the inaugural 2025 cohort and also marked the announcement of the 2026 cohort, comprised of 33 scholars.

Medical Student Breakfast
Preceding the Symposium, 150 medical students, dermatology residents, dermatology program directors, and dermatologist leaders gathered for the 2nd Annual Medical Student Breakfast, hosted in partnership with Clinique.

This unique mentoring program featured insights and inspiration for aspiring dermatologists, including open, practical conversations about the residency application process, mentorship relationships, and the future of dermatology, including the following presentations:

  • Opening remarks from SOCS President Dr. Nada Elbuluk
  • “From Student to Specialist: A Dermatologist’s Journey,” presented by SOCS leader Dr. Caroline Robinson
  • Pathway to Dermatology Panel: “The Match and Mentorship Journey” with program directors, Drs. Julia Riley and Jarad Levin, and dermatology residents, Drs. Kala Hurst and Gisselle Pichardo, moderated by Dr. Victoria Barbosa, with a robust Q & A period.
  • Sponsor Spotlight, featuring Kelly Fanning, SVP General Manager, Clinique North America
  • Closing remarks from Dr. Barbosa

The multi-faceted initiative is led by the SOCS Center for Leadership, co-chaired by Drs. Victoria Barbosa and Katrina Abuabara.

“We are thrilled to continue the longstanding SOCS tradition of showcasing seminal research and key insights from emerging researchers and accomplished experts to advance knowledge and understanding of dermatologic diseases and conditions in skin of color through our annual scientific symposium. We are grateful for our global community of distinguished dermatology leaders, members, investigators, trainees, and industry supporters from around the globe who contributed to the success and impact of this yearly program,” comments Dr. Nada Elbuluk.

The Society will present its 23rd Annual SOCS Scientific Symposium on Thursday, March 18, 2027, in San Francisco, California.

About the Skin of Color Society (SOCS)
The Skin of Color Society (SOCS) is the world’s leading professional dermatologic organization dedicated to advancing the field of skin of color dermatology. Founded in 2004 by Dr. Susan C. Taylor, SOCS is driven by the mission to achieve health equity and excellence in patient care through research, education, mentorship, and advocacy. With members representing 22 countries, SOCS membership includes highly skilled dermatologists across dermatology subspecialties (medical, cosmetic, and surgical), and practice settings (private practice, public service, and academia). The Society has mentored hundreds of medical students, dermatology residents, and fellows and awarded numerous research, fellowship, mentorship, observership, career development, and innovation grants to early and mid-career dermatologists. The work of the Society is supported by the Skin of Color Society Foundation (SOCSF). skinofcolorsociety.org

 

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/the-skin-of-color-society-socs-successfully-presents-landmark-symposium-championing-evidence-based-dermatology-and-collaboration-302748350.html

SOURCE Skin of Color Society

The 22nd annual event convened nearly 500 attendees from 13 countries, featuring insightful scientific presentations, panels, and a keynote session by 18th U.S. Surgeon General Dr. Regina Benjamin, following a groundbreaking medical student breakfast program.

CHICAGO, April 21, 2026 /PRNewswire/ — The Skin of Color Society (SOCS), the world’s leading professional society dedicated to advancing skin of color dermatology, successfully presented its 22nd Annual Scientific Symposium, “Championing Evidence-Based Dermatology and Collaboration,” on March 26, 2026, in Denver, Colorado. Held in conjunction with the American Academy of Dermatology (AAD) Annual Meeting, this signature SOCS program convened nearly 500 attendees from 13 countries.

 

Drs. Janiene Luke and Temitayo Ogunleye co-chaired the dynamic program developed under the leadership of the SOCS Scientific Meetings Committee. The innovative scientific program showcased insights from highly recognized experts, dermatology leaders, and emerging researchers, featuring the following presentations:

  • Welcome remarks by SOCS President Dr. Nada Elbuluk (now Immediate Past President)
  • Keynote session, Making a Difference, presented by Dr. Regina Benjamin
  • Leadership During Turbulent Times presented by SOCS Founder Dr. Susan C. Taylor
  • Tumor Microenvironment Signatures in CTCL: Implications for Personalized Medicine, presented by Dr. Courtney M. Johnson, 2021 Dermatology Research Award Recipient
  • Risk of Psychiatric Comorbidities in Scarring vs Non-Scarring Alopecia: A Retrospective Cohort Study, an oral abstract presented by Nicole J. Baker, BS
  • Presentations by Early Career Innovations Award Finalists, judged by award founder Dr. Dhaval Bhanusali, and Drs. Tiffany Mayo and Roopal Kundu:
    • Short Wave Infrared (SWIR) Imaging to Detect Early Hair Regrowth in Alopecia presented by Angela Anaeme, BS, Washington University in St. Louis School of Medicine
    • LearnDx, presented by Priyanka Kadam, BS, Stony Brook University Renaissance School of Medicine
  • Limitations for Gender Affirming Care in Challenging Times, presented by Dr. Klint Peebles
  • Holistic Patient Care & Advocacy Panel, moderated by Dr. Heather Woolery-Lloyd with panelists Drs. Michelle Oboite, Klint Peebles, and Rebecca Vasquez
  • Distinct Metabolic Pathways of Hidradenitis Suppurativa and Severity-Associated Biomarkers, an oral abstract presented by Kingsley Osei-Karikari, BA, Weill Cornell Medical College, 4th Year Medical Student
  • Perioperative Racial Disparities in Patients with Acral Lentiginous Melanoma Undergoing Mohs Micrographic Surgery, an oral abstract presented by Umayr R. Shaikh, MPH
  • Leveraging AI to Build a More Sustainable Dermatology Practice presented by Dr. Vinod E. Nambudiri
  • Physician Care & Wellness: Practical Strategies for Sustainable Practice Panel, moderated by Dr. Noreen Galaria, with panelists Drs. Naana A. Boakye, Vinod E. Nambudiri, Karolyn Wanat, and Heather Woolery-Lloyd
  • Closing remarks by Dr. Nada Elbuluk

In addition to these formal presentations, several scientific iPosters developed by emerging skin of color dermatology researchers were featured during the program breaks throughout the afternoon.

The 22nd Annual SOCS Scientific Symposium was made possible thanks to the generous support of the following sponsors: AbbVie and Johnson & Johnson (Champion Level); Arcutis Biotherapeutics, Bristol Myers Squibb, Clinique, Eli Lilly & Co, Incyte, Sanofi and Regeneron (Ally level); Pfizer and UCB (Partner level); Beiersdorf, Biogen, Clinuvel, LEO Pharmaceuticals, Organon, Ortho Dermatologics, Takeda, and Vaseline (Friend level); Dr. Dhaval Bhanusali, EltaMD Skincare, Novartis, SkinCeuticals, Sun Pharmaceuticals (Special Acknowledgements).

Additional support for the Society’s work was made possible thanks to individual donors to the SOCS Foundation, who received special access to a Donor Wellness Lounge throughout the day.

2026 Grants and Awards Presented
Several prestigious SOCS awards, grants, and special recognition were presented during the Symposium, including: 

SOCS Career Development Award 
Dr. Leandra A. Barnes, Stanford Medicine, Department of Dermatology, for “Investigating the Role of Geospatial Social Determinants of Health in Diagnosis and Healthcare Inequities in Hidradenitis Suppurativa (HS): A Mixed-Methods and Machine Learning Approach.”

2026 Dermatology Research Award
Dr. William Lewis, Beth Israel Deaconess Medical Center, Harvard Medical School, for “Clinical Validation of an Erythema Imaging Tool for Assessment of Inflammation in Skin of Color.”     

2026 Dermatology Foundation-Skin of Color Society Collaborative Mid-Career Award sponsored by Sanofi and Regeneron

  • Dr. Angel S. Byrd, Howard University, for “Understanding the Role of Pathogen-Mediated Immune Dysregulation in Hidradenitis Suppurativa.” (Special bestowal of available 2025 funding.) 
  • Dr. Tarannum Jaleel, Duke University Medical Center Dermatology, for “AR Signaling and CXCL12-Mediated Neutrophil Retention in Hidradenitis Suppurativa.”

2026 Early Career Innovations Award
Priyanka Kadam, BS, Stony Brook University Renaissance School of Medicine for Learn Dx.
This award is made possible thanks to Dr. Dhaval Bhanusali and EltaMD Skincare.

2026 Institutional Research Fellowship Awards
Duke University
University of Pennsylvania
This award is sponsored by Johnson & Johnson.

The Center for Leadership Resident Leader Award 
Dr. Kala Hurst, Dermatology Resident PGY-4, Case Western Reserve University, University Hospitals.
This award is supported by Eli Lilly & Co.

2026 Best iPoster Presentation
Shirin Shahsavari, BS, Johns Hopkins University School of Medicine, Department of Dermatology, for “Tumor Microenvironment Remodeling in Mycosis Fungoides Across Diverse Patient Cohorts Revealed by Single-Cell Transcriptomics.”

2026 Best Oral Abstract Presentation
Umayr R. Shaikh, MPH, Georgetown University, School of Medicine, 4th Year Medical Student for “Perioperative Racial Disparities in Patients with Acral Lentiginous Melanoma Undergoing Mohs Micrographic Surgery.”

Inaugural SOCS Awards
In recognition of extraordinary contributions to the specialty, SOCS Founder Dr. Susan C. Taylor received the Skin of Color Champion of the Year, and Past President and Founding Member Dr. Valerie C. Callender received the Mentor of the Year Award.

Clinical Investigator Training and Mentorship Program
Mentors and mentees from the 2024, 2025, and 2026 cohorts were recognized for their participation in this groundbreaking training and mentorship initiative presented collaboratively by SOCS and the National Medical Association (NMA) Dermatology Section, listed here.
This program is supported by Johnson & Johnson.

Dermatologists of Tomorrow Scholarship (DOTS) presented by SOCS Foundation (SOCSF) and Cliniqu
We are proud to continue our partnership with Clinique via the Dermatologists of Tomorrow Scholarship (DOTS).  Rooted in mentorship, this pioneering partnership was built to provide support to medical students interested in pursuing careers in dermatology and health equity. The Symposium celebrated the inaugural 2025 cohort and also marked the announcement of the 2026 cohort, comprised of 33 scholars.

Medical Student Breakfast
Preceding the Symposium, 150 medical students, dermatology residents, dermatology program directors, and dermatologist leaders gathered for the 2nd Annual Medical Student Breakfast, hosted in partnership with Clinique.

This unique mentoring program featured insights and inspiration for aspiring dermatologists, including open, practical conversations about the residency application process, mentorship relationships, and the future of dermatology, including the following presentations:

  • Opening remarks from SOCS President Dr. Nada Elbuluk
  • “From Student to Specialist: A Dermatologist’s Journey,” presented by SOCS leader Dr. Caroline Robinson
  • Pathway to Dermatology Panel: “The Match and Mentorship Journey” with program directors, Drs. Julia Riley and Jarad Levin, and dermatology residents, Drs. Kala Hurst and Gisselle Pichardo, moderated by Dr. Victoria Barbosa, with a robust Q & A period.
  • Sponsor Spotlight, featuring Kelly Fanning, SVP General Manager, Clinique North America
  • Closing remarks from Dr. Barbosa

The multi-faceted initiative is led by the SOCS Center for Leadership, co-chaired by Drs. Victoria Barbosa and Katrina Abuabara.

“We are thrilled to continue the longstanding SOCS tradition of showcasing seminal research and key insights from emerging researchers and accomplished experts to advance knowledge and understanding of dermatologic diseases and conditions in skin of color through our annual scientific symposium. We are grateful for our global community of distinguished dermatology leaders, members, investigators, trainees, and industry supporters from around the globe who contributed to the success and impact of this yearly program,” comments Dr. Nada Elbuluk.

The Society will present its 23rd Annual SOCS Scientific Symposium on Thursday, March 18, 2027, in San Francisco, California.

About the Skin of Color Society (SOCS)
The Skin of Color Society (SOCS) is the world’s leading professional dermatologic organization dedicated to advancing the field of skin of color dermatology. Founded in 2004 by Dr. Susan C. Taylor, SOCS is driven by the mission to achieve health equity and excellence in patient care through research, education, mentorship, and advocacy. With members representing 22 countries, SOCS membership includes highly skilled dermatologists across dermatology subspecialties (medical, cosmetic, and surgical), and practice settings (private practice, public service, and academia). The Society has mentored hundreds of medical students, dermatology residents, and fellows and awarded numerous research, fellowship, mentorship, observership, career development, and innovation grants to early and mid-career dermatologists. The work of the Society is supported by the Skin of Color Society Foundation (SOCSF). skinofcolorsociety.org

 

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/the-skin-of-color-society-socs-successfully-presents-landmark-symposium-championing-evidence-based-dermatology-and-collaboration-302748350.html

SOURCE Skin of Color Society

The 22nd annual event convened nearly 500 attendees from 13 countries, featuring insightful scientific presentations, panels, and a keynote session by 18th U.S. Surgeon General Dr. Regina Benjamin, following a groundbreaking medical student breakfast program.

CHICAGO, April 21, 2026 /PRNewswire/ — The Skin of Color Society (SOCS), the world’s leading professional society dedicated to advancing skin of color dermatology, successfully presented its 22nd Annual Scientific Symposium, “Championing Evidence-Based Dermatology and Collaboration,” on March 26, 2026, in Denver, Colorado. Held in conjunction with the American Academy of Dermatology (AAD) Annual Meeting, this signature SOCS program convened nearly 500 attendees from 13 countries.

 

Drs. Janiene Luke and Temitayo Ogunleye co-chaired the dynamic program developed under the leadership of the SOCS Scientific Meetings Committee. The innovative scientific program showcased insights from highly recognized experts, dermatology leaders, and emerging researchers, featuring the following presentations:

  • Welcome remarks by SOCS President Dr. Nada Elbuluk (now Immediate Past President)
  • Keynote session, Making a Difference, presented by Dr. Regina Benjamin
  • Leadership During Turbulent Times presented by SOCS Founder Dr. Susan C. Taylor
  • Tumor Microenvironment Signatures in CTCL: Implications for Personalized Medicine, presented by Dr. Courtney M. Johnson, 2021 Dermatology Research Award Recipient
  • Risk of Psychiatric Comorbidities in Scarring vs Non-Scarring Alopecia: A Retrospective Cohort Study, an oral abstract presented by Nicole J. Baker, BS
  • Presentations by Early Career Innovations Award Finalists, judged by award founder Dr. Dhaval Bhanusali, and Drs. Tiffany Mayo and Roopal Kundu:
    • Short Wave Infrared (SWIR) Imaging to Detect Early Hair Regrowth in Alopecia presented by Angela Anaeme, BS, Washington University in St. Louis School of Medicine
    • LearnDx, presented by Priyanka Kadam, BS, Stony Brook University Renaissance School of Medicine
  • Limitations for Gender Affirming Care in Challenging Times, presented by Dr. Klint Peebles
  • Holistic Patient Care & Advocacy Panel, moderated by Dr. Heather Woolery-Lloyd with panelists Drs. Michelle Oboite, Klint Peebles, and Rebecca Vasquez
  • Distinct Metabolic Pathways of Hidradenitis Suppurativa and Severity-Associated Biomarkers, an oral abstract presented by Kingsley Osei-Karikari, BA, Weill Cornell Medical College, 4th Year Medical Student
  • Perioperative Racial Disparities in Patients with Acral Lentiginous Melanoma Undergoing Mohs Micrographic Surgery, an oral abstract presented by Umayr R. Shaikh, MPH
  • Leveraging AI to Build a More Sustainable Dermatology Practice presented by Dr. Vinod E. Nambudiri
  • Physician Care & Wellness: Practical Strategies for Sustainable Practice Panel, moderated by Dr. Noreen Galaria, with panelists Drs. Naana A. Boakye, Vinod E. Nambudiri, Karolyn Wanat, and Heather Woolery-Lloyd
  • Closing remarks by Dr. Nada Elbuluk

In addition to these formal presentations, several scientific iPosters developed by emerging skin of color dermatology researchers were featured during the program breaks throughout the afternoon.

The 22nd Annual SOCS Scientific Symposium was made possible thanks to the generous support of the following sponsors: AbbVie and Johnson & Johnson (Champion Level); Arcutis Biotherapeutics, Bristol Myers Squibb, Clinique, Eli Lilly & Co, Incyte, Sanofi and Regeneron (Ally level); Pfizer and UCB (Partner level); Beiersdorf, Biogen, Clinuvel, LEO Pharmaceuticals, Organon, Ortho Dermatologics, Takeda, and Vaseline (Friend level); Dr. Dhaval Bhanusali, EltaMD Skincare, Novartis, SkinCeuticals, Sun Pharmaceuticals (Special Acknowledgements).

Additional support for the Society’s work was made possible thanks to individual donors to the SOCS Foundation, who received special access to a Donor Wellness Lounge throughout the day.

2026 Grants and Awards Presented
Several prestigious SOCS awards, grants, and special recognition were presented during the Symposium, including: 

SOCS Career Development Award 
Dr. Leandra A. Barnes, Stanford Medicine, Department of Dermatology, for “Investigating the Role of Geospatial Social Determinants of Health in Diagnosis and Healthcare Inequities in Hidradenitis Suppurativa (HS): A Mixed-Methods and Machine Learning Approach.”

2026 Dermatology Research Award
Dr. William Lewis, Beth Israel Deaconess Medical Center, Harvard Medical School, for “Clinical Validation of an Erythema Imaging Tool for Assessment of Inflammation in Skin of Color.”     

2026 Dermatology Foundation-Skin of Color Society Collaborative Mid-Career Award sponsored by Sanofi and Regeneron

  • Dr. Angel S. Byrd, Howard University, for “Understanding the Role of Pathogen-Mediated Immune Dysregulation in Hidradenitis Suppurativa.” (Special bestowal of available 2025 funding.) 
  • Dr. Tarannum Jaleel, Duke University Medical Center Dermatology, for “AR Signaling and CXCL12-Mediated Neutrophil Retention in Hidradenitis Suppurativa.”

2026 Early Career Innovations Award
Priyanka Kadam, BS, Stony Brook University Renaissance School of Medicine for Learn Dx.
This award is made possible thanks to Dr. Dhaval Bhanusali and EltaMD Skincare.

2026 Institutional Research Fellowship Awards
Duke University
University of Pennsylvania
This award is sponsored by Johnson & Johnson.

The Center for Leadership Resident Leader Award 
Dr. Kala Hurst, Dermatology Resident PGY-4, Case Western Reserve University, University Hospitals.
This award is supported by Eli Lilly & Co.

2026 Best iPoster Presentation
Shirin Shahsavari, BS, Johns Hopkins University School of Medicine, Department of Dermatology, for “Tumor Microenvironment Remodeling in Mycosis Fungoides Across Diverse Patient Cohorts Revealed by Single-Cell Transcriptomics.”

2026 Best Oral Abstract Presentation
Umayr R. Shaikh, MPH, Georgetown University, School of Medicine, 4th Year Medical Student for “Perioperative Racial Disparities in Patients with Acral Lentiginous Melanoma Undergoing Mohs Micrographic Surgery.”

Inaugural SOCS Awards
In recognition of extraordinary contributions to the specialty, SOCS Founder Dr. Susan C. Taylor received the Skin of Color Champion of the Year, and Past President and Founding Member Dr. Valerie C. Callender received the Mentor of the Year Award.

Clinical Investigator Training and Mentorship Program
Mentors and mentees from the 2024, 2025, and 2026 cohorts were recognized for their participation in this groundbreaking training and mentorship initiative presented collaboratively by SOCS and the National Medical Association (NMA) Dermatology Section, listed here.
This program is supported by Johnson & Johnson.

Dermatologists of Tomorrow Scholarship (DOTS) presented by SOCS Foundation (SOCSF) and Cliniqu
We are proud to continue our partnership with Clinique via the Dermatologists of Tomorrow Scholarship (DOTS).  Rooted in mentorship, this pioneering partnership was built to provide support to medical students interested in pursuing careers in dermatology and health equity. The Symposium celebrated the inaugural 2025 cohort and also marked the announcement of the 2026 cohort, comprised of 33 scholars.

Medical Student Breakfast
Preceding the Symposium, 150 medical students, dermatology residents, dermatology program directors, and dermatologist leaders gathered for the 2nd Annual Medical Student Breakfast, hosted in partnership with Clinique.

This unique mentoring program featured insights and inspiration for aspiring dermatologists, including open, practical conversations about the residency application process, mentorship relationships, and the future of dermatology, including the following presentations:

  • Opening remarks from SOCS President Dr. Nada Elbuluk
  • “From Student to Specialist: A Dermatologist’s Journey,” presented by SOCS leader Dr. Caroline Robinson
  • Pathway to Dermatology Panel: “The Match and Mentorship Journey” with program directors, Drs. Julia Riley and Jarad Levin, and dermatology residents, Drs. Kala Hurst and Gisselle Pichardo, moderated by Dr. Victoria Barbosa, with a robust Q & A period.
  • Sponsor Spotlight, featuring Kelly Fanning, SVP General Manager, Clinique North America
  • Closing remarks from Dr. Barbosa

The multi-faceted initiative is led by the SOCS Center for Leadership, co-chaired by Drs. Victoria Barbosa and Katrina Abuabara.

“We are thrilled to continue the longstanding SOCS tradition of showcasing seminal research and key insights from emerging researchers and accomplished experts to advance knowledge and understanding of dermatologic diseases and conditions in skin of color through our annual scientific symposium. We are grateful for our global community of distinguished dermatology leaders, members, investigators, trainees, and industry supporters from around the globe who contributed to the success and impact of this yearly program,” comments Dr. Nada Elbuluk.

The Society will present its 23rd Annual SOCS Scientific Symposium on Thursday, March 18, 2027, in San Francisco, California.

About the Skin of Color Society (SOCS)
The Skin of Color Society (SOCS) is the world’s leading professional dermatologic organization dedicated to advancing the field of skin of color dermatology. Founded in 2004 by Dr. Susan C. Taylor, SOCS is driven by the mission to achieve health equity and excellence in patient care through research, education, mentorship, and advocacy. With members representing 22 countries, SOCS membership includes highly skilled dermatologists across dermatology subspecialties (medical, cosmetic, and surgical), and practice settings (private practice, public service, and academia). The Society has mentored hundreds of medical students, dermatology residents, and fellows and awarded numerous research, fellowship, mentorship, observership, career development, and innovation grants to early and mid-career dermatologists. The work of the Society is supported by the Skin of Color Society Foundation (SOCSF). skinofcolorsociety.org

 

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/the-skin-of-color-society-socs-successfully-presents-landmark-symposium-championing-evidence-based-dermatology-and-collaboration-302748350.html

SOURCE Skin of Color Society